Heartbeam Inc (BEAT)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Heartbeam Inc Stock (BEAT) Company Profile

Heartbeam Inc

Healthcare (1161)

408-899-4443

2118 WALSH AVE., SUITE 210, SANTA CLARA

Prossima data di guadagno

Ultimi documenti SEC

BEAT's Discussions on Twitter

Confronta BEAT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BEAT Heartbeam Inc	1.9198	66.78M	0	-14.47M	-12.19M	-1.24
VEEV Veeva Systems Inc	223.76	36.00B	2.75B	714.14M	1.09B	4.33
DOCS Doximity Inc	54.91	10.33B	516.85M	174.11M	217.38M	0.87
TEM Tempus Ai Inc	46.62	8.16B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	84.65	7.17B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	36.66	6.24B	906.14M	-52.62M	89.62M	-0.3621

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2020-09-11	Iniziato	Needham	Buy
2020-09-02	Iniziato	Robert W. Baird	Neutral
2020-01-08	Iniziato	SunTrust	Buy
2019-08-02	Downgrade	Raymond James	Outperform → Mkt Perform
2019-04-26	Reiterato	Dougherty & Company	Buy
2018-07-26	Reiterato	Lake Street	Buy
2018-04-26	Reiterato	The Benchmark Company	Buy
2018-02-23	Reiterato	Dougherty & Company	Buy
2017-11-08	Reiterato	Dougherty & Company	Buy
2017-10-26	Iniziato	Raymond James	Outperform
2017-10-24	Iniziato	SunTrust	Buy
2017-08-09	Reiterato	Dougherty & Company	Buy
2017-07-19	Reiterato	The Benchmark Company	Buy
2017-04-11	Reiterato	Dougherty & Company	Buy
2016-12-02	Iniziato	Dougherty & Company	Buy
2016-09-13	Iniziato	Sidoti	Buy
2016-08-03	Reiterato	The Benchmark Company	Buy
2015-07-28	Reiterato	Dougherty & Company	Buy
2013-10-24	Iniziato	The Benchmark Company	Buy
2013-08-21	Iniziato	Dougherty & Company	Buy

Mostra tutto

Heartbeam Inc Borsa (BEAT) Ultime notizie

Heartbeam Inc Azioni (BEAT) Dati Finanziari

Heartbeam Inc (BEAT)

Heartbeam Inc Stock (BEAT) Company Profile

Confronta BEAT con altri titoli

Heartbeam Inc Stock (BEAT) Upgrades & Downgrades

Heartbeam Inc Borsa (BEAT) Ultime notizie

Benchmark maintains $8 target on Heartbeam stock post-Q4 report - Investing.com

Benchmark maintains $8 target on Heartbeam stock post-Q4 report By Investing.com - Investing.com South Africa

HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System - Business Wire

HeartBeam reports net loss of USD 4.9M in Q4 2024 - Medical Buyer

HeartBeam, Inc. (NASDAQ:BEAT) Q4 2024 Earnings Call Transcript - Insider Monkey

HeartBeam’s Earnings Call Highlights Strategic Progress - TipRanks

HeartBeam (NASDAQ: BEAT) Reports Q4 and Full-Year 2024 Financial Results, Highlights FDA Clearance and Commercial Progress - The Globe and Mail

HeartBeam Inc (BEAT) Q4 2024 Earnings Call Highlights: FDA Clearance and Strategic Moves By GuruFocus - Investing.com Canada

HeartBeam Advances Cardiac Care with FDA Clearance and New Innovations - TipRanks

Earnings call transcript: HeartBEAM Q4 2024 misses EPS forecasts - Investing.com

HeartBeam Reports Fourth Quarter and Full Year 2024 Results -March 13, 2025 at 05:31 pm EDT - Marketscreener.com

Heartbeam Inc reports results for the quarter ended December 31Earnings Summary - TradingView

HeartBeam Reports Fourth Quarter and Full Year 2024 Results - Business Wire

HeartBeam (NASDAQ: BEAT) To Present At Upcoming Investor And Industry Conferences - Barchart

HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025 - The Bakersfield Californian

Meet HeartBeam Executives: Key Investment Conferences Set for California Next Month - StockTitan

HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time - The Bakersfield Californian

HeartBeam (NASDAQ: BEAT) Underwriter Exercises Option, Increasing Gross Proceeds to $11.5M - The Globe and Mail

HeartBeam closes underwriter’s over-allotment option for PO - Medical Buyer

HeartBeam Raises $11.5M: What This Capital Injection Means for Its Commercial Launch Timeline - StockTitan

Heartbeam CFO Tim Cruickshank buys $29,999 in company stock - Investing.com India

Heartbeam director Richard Ferrari buys $50,000 in stock By Investing.com - Investing.com Australia

Heartbeam director Richard Ferrari buys $50,000 in stock - Investing.com India

Heartbeam CFO Tim Cruickshank buys $29,999 in company stock By Investing.com - Investing.com Nigeria

HeartBeam announces pricing of UPO - Medical Buyer

HeartBeam submits 510(k) application to FDA for ECG software - MSN

HeartBeam sets price for $10 million stock offering - MSN

HeartBeam prices public offering of 5.88M shares; shares down - MSN

HeartBeam Secures Major Funding: FDA-Cleared Cardiac Innovation Gets $10M Boost - StockTitan

US Penny Stocks Spotlight: HeartBeam And Two More Standout Picks - Yahoo Finance

HeartBeam (NASDAQ: BEAT) Submits FDA Application for 12-Lead ECG Synthesis Software - The Globe and Mail

HeartBeam seeks FDA nod for ECG synthesis software - MSN

HeartBeam Submits 12-Lead ECG Synthesis Software to FDA - MPO-mag

BEATHeartbeam, Inc. Latest Stock News & Market Updates - StockTitan

HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software - Business Wire

This Tiny Medical Device Could Transform Heart Attack DetectionHeartBeam's Game-Changing FDA Filing - Stock Titan

Blaize Appoints Yoshiaki Fujimori and George de Urioste to Board of Directors - Business Wire

JP Morgan Chase & Company (JPM-N) QuotePress Release - The Globe and Mail

HeartBeam (NASDAQ: BEAT) To Present At JP Morgan 2025 Annual Healthcare Conference - Barchart

Heartbeam Inc (BEAT-Q) QuotePress Release - The Globe and Mail

HeartBeam to Showcase FDA-Cleared Revolutionary Heart Monitor at JP Morgan Healthcare Conference - StockTitan

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference - Business Wire

HeartBeam’s arrhythmia assessment system gains FDA 510(k) clearance - Yahoo! Voices

Heartbeam Inc Azioni (BEAT) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a BEAT